nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxycycline—MMP8—Matrix Metalloproteinases—TIMP2—intracranial aneurysm	0.0442	0.0452	CbGpPWpGaD
Doxycycline—MMP8—Activation of Matrix Metalloproteinases—TIMP2—intracranial aneurysm	0.0419	0.0429	CbGpPWpGaD
Doxycycline—MMP13—Matrix Metalloproteinases—TIMP2—intracranial aneurysm	0.0322	0.0329	CbGpPWpGaD
Doxycycline—MMP7—Matrix Metalloproteinases—TIMP2—intracranial aneurysm	0.0311	0.0318	CbGpPWpGaD
Doxycycline—MMP13—Activation of Matrix Metalloproteinases—TIMP2—intracranial aneurysm	0.0306	0.0313	CbGpPWpGaD
Doxycycline—MMP7—Activation of Matrix Metalloproteinases—TIMP2—intracranial aneurysm	0.0295	0.0302	CbGpPWpGaD
Doxycycline—MMP1—Matrix Metalloproteinases—TIMP2—intracranial aneurysm	0.0249	0.0254	CbGpPWpGaD
Doxycycline—MMP1—Activation of Matrix Metalloproteinases—TIMP2—intracranial aneurysm	0.0236	0.0242	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—TIMP2—intracranial aneurysm	0.0185	0.0189	CbGpPWpGaD
Doxycycline—MMP8—Activation of Matrix Metalloproteinases—CTSK—intracranial aneurysm	0.0183	0.0187	CbGpPWpGaD
Doxycycline—MMP8—Collagen degradation—CTSK—intracranial aneurysm	0.0159	0.0163	CbGpPWpGaD
Doxycycline—MMP8—Matrix Metalloproteinases—TIMP1—intracranial aneurysm	0.0146	0.0149	CbGpPWpGaD
Doxycycline—MMP8—Activation of Matrix Metalloproteinases—TIMP1—intracranial aneurysm	0.0138	0.0141	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—TIMP2—intracranial aneurysm	0.0135	0.0138	CbGpPWpGaD
Doxycycline—MMP13—Activation of Matrix Metalloproteinases—CTSK—intracranial aneurysm	0.0133	0.0136	CbGpPWpGaD
Doxycycline—MMP8—Collagen degradation—CTSB—intracranial aneurysm	0.0132	0.0135	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—TIMP2—intracranial aneurysm	0.013	0.0133	CbGpPWpGaD
Doxycycline—MMP7—Activation of Matrix Metalloproteinases—CTSK—intracranial aneurysm	0.0129	0.0132	CbGpPWpGaD
Doxycycline—MMP13—Collagen degradation—CTSK—intracranial aneurysm	0.0116	0.0119	CbGpPWpGaD
Doxycycline—MMP7—Collagen degradation—CTSK—intracranial aneurysm	0.0112	0.0115	CbGpPWpGaD
Doxycycline—MMP13—Matrix Metalloproteinases—TIMP1—intracranial aneurysm	0.0106	0.0109	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—TIMP2—intracranial aneurysm	0.0104	0.0107	CbGpPWpGaD
Doxycycline—MMP1—Activation of Matrix Metalloproteinases—CTSK—intracranial aneurysm	0.0103	0.0105	CbGpPWpGaD
Doxycycline—MMP7—Matrix Metalloproteinases—TIMP1—intracranial aneurysm	0.0103	0.0105	CbGpPWpGaD
Doxycycline—MMP13—Activation of Matrix Metalloproteinases—TIMP1—intracranial aneurysm	0.0101	0.0103	CbGpPWpGaD
Doxycycline—MMP13—Assembly of collagen fibrils and other multimeric structures—CTSS—intracranial aneurysm	0.00981	0.01	CbGpPWpGaD
Doxycycline—MMP7—Activation of Matrix Metalloproteinases—TIMP1—intracranial aneurysm	0.00975	0.00997	CbGpPWpGaD
Doxycycline—MMP13—Collagen degradation—CTSB—intracranial aneurysm	0.00961	0.00983	CbGpPWpGaD
Doxycycline—Minocycline—MMP9—intracranial aneurysm	0.00955	1	CrCbGaD
Doxycycline—MMP7—Assembly of collagen fibrils and other multimeric structures—CTSS—intracranial aneurysm	0.00948	0.00969	CbGpPWpGaD
Doxycycline—MMP7—Collagen degradation—CTSB—intracranial aneurysm	0.00928	0.00949	CbGpPWpGaD
Doxycycline—MMP1—Collagen degradation—CTSK—intracranial aneurysm	0.00896	0.00917	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—CTSS—intracranial aneurysm	0.00875	0.00895	CbGpPWpGaD
Doxycycline—MMP1—Matrix Metalloproteinases—TIMP1—intracranial aneurysm	0.00821	0.00839	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—CTSK—intracranial aneurysm	0.00805	0.00824	CbGpPWpGaD
Doxycycline—SLC22A8—choroid plexus—intracranial aneurysm	0.00791	0.623	CbGeAlD
Doxycycline—MMP1—Activation of Matrix Metalloproteinases—TIMP1—intracranial aneurysm	0.00779	0.00797	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—TIMP2—intracranial aneurysm	0.00775	0.00793	CbGpPWpGaD
Doxycycline—MMP13—Assembly of collagen fibrils and other multimeric structures—CTSB—intracranial aneurysm	0.00748	0.00765	CbGpPWpGaD
Doxycycline—MMP1—Collagen degradation—CTSB—intracranial aneurysm	0.00742	0.00759	CbGpPWpGaD
Doxycycline—MMP7—Assembly of collagen fibrils and other multimeric structures—CTSB—intracranial aneurysm	0.00722	0.00738	CbGpPWpGaD
Doxycycline—MMP8—Matrix Metalloproteinases—MMP2—intracranial aneurysm	0.00701	0.00717	CbGpPWpGaD
Doxycycline—MMP13—Collagen formation—CTSS—intracranial aneurysm	0.00669	0.00684	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—CTSB—intracranial aneurysm	0.00667	0.00682	CbGpPWpGaD
Doxycycline—MMP8—Activation of Matrix Metalloproteinases—MMP2—intracranial aneurysm	0.00666	0.00681	CbGpPWpGaD
Doxycycline—MMP7—Collagen formation—CTSS—intracranial aneurysm	0.00646	0.0066	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—CTSS—intracranial aneurysm	0.00638	0.00653	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—CTSS—intracranial aneurysm	0.00617	0.00631	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—NCF1—intracranial aneurysm	0.00615	0.00629	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—TIMP1—intracranial aneurysm	0.0061	0.00624	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—NCF1—intracranial aneurysm	0.00594	0.00607	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—CTSK—intracranial aneurysm	0.00588	0.00601	CbGpPWpGaD
Doxycycline—MMP8—Collagen degradation—MMP2—intracranial aneurysm	0.0058	0.00593	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—CTSK—intracranial aneurysm	0.00567	0.0058	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—TIMP2—intracranial aneurysm	0.00566	0.00578	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—ELN—intracranial aneurysm	0.00552	0.00565	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—TIMP2—intracranial aneurysm	0.00546	0.00559	CbGpPWpGaD
Doxycycline—MMP8—Matrix Metalloproteinases—MMP9—intracranial aneurysm	0.00527	0.00539	CbGpPWpGaD
Doxycycline—MMP1—Regulation of IGF Activity by IGFBP—MMP2—intracranial aneurysm	0.00525	0.00537	CbGpPWpGaD
Doxycycline—MMP13—Matrix Metalloproteinases—MMP2—intracranial aneurysm	0.00511	0.00523	CbGpPWpGaD
Doxycycline—MMP13—Collagen formation—CTSB—intracranial aneurysm	0.00509	0.00521	CbGpPWpGaD
Doxycycline—MMP8—Activation of Matrix Metalloproteinases—MMP9—intracranial aneurysm	0.005	0.00512	CbGpPWpGaD
Doxycycline—MMP7—Matrix Metalloproteinases—MMP2—intracranial aneurysm	0.00494	0.00505	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—CTSS—intracranial aneurysm	0.00493	0.00504	CbGpPWpGaD
Doxycycline—MMP7—Collagen formation—CTSB—intracranial aneurysm	0.00492	0.00503	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—CTSB—intracranial aneurysm	0.00486	0.00497	CbGpPWpGaD
Doxycycline—MMP13—Activation of Matrix Metalloproteinases—MMP2—intracranial aneurysm	0.00486	0.00497	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—CTSB—intracranial aneurysm	0.0047	0.0048	CbGpPWpGaD
Doxycycline—MMP7—Activation of Matrix Metalloproteinases—MMP2—intracranial aneurysm	0.00469	0.0048	CbGpPWpGaD
Doxycycline—MMP1—Endothelins—EDNRA—intracranial aneurysm	0.00465	0.00476	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—CTSK—intracranial aneurysm	0.00454	0.00464	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—TIMP1—intracranial aneurysm	0.00445	0.00455	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—TIMP2—intracranial aneurysm	0.00437	0.00447	CbGpPWpGaD
Doxycycline—MMP8—Collagen degradation—MMP9—intracranial aneurysm	0.00436	0.00446	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—TIMP1—intracranial aneurysm	0.0043	0.0044	CbGpPWpGaD
Doxycycline—MMP13—Collagen degradation—MMP2—intracranial aneurysm	0.00423	0.00433	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—TIMP1—intracranial aneurysm	0.00417	0.00426	CbGpPWpGaD
Doxycycline—MMP1—artery—intracranial aneurysm	0.00411	0.324	CbGeAlD
Doxycycline—MMP7—Collagen degradation—MMP2—intracranial aneurysm	0.00409	0.00418	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—ELN—intracranial aneurysm	0.00403	0.00412	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—AGER—intracranial aneurysm	0.00399	0.00408	CbGpPWpGaD
Doxycycline—MMP1—Matrix Metalloproteinases—MMP2—intracranial aneurysm	0.00395	0.00404	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—ELN—intracranial aneurysm	0.00389	0.00398	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—AGER—intracranial aneurysm	0.00385	0.00394	CbGpPWpGaD
Doxycycline—MMP13—Matrix Metalloproteinases—MMP9—intracranial aneurysm	0.00384	0.00393	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—CTSB—intracranial aneurysm	0.00375	0.00384	CbGpPWpGaD
Doxycycline—MMP1—Activation of Matrix Metalloproteinases—MMP2—intracranial aneurysm	0.00375	0.00383	CbGpPWpGaD
Doxycycline—MMP7—Matrix Metalloproteinases—MMP9—intracranial aneurysm	0.00371	0.0038	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—CTSS—intracranial aneurysm	0.00367	0.00375	CbGpPWpGaD
Doxycycline—MMP13—Activation of Matrix Metalloproteinases—MMP9—intracranial aneurysm	0.00365	0.00373	CbGpPWpGaD
Doxycycline—MMP7—Activation of Matrix Metalloproteinases—MMP9—intracranial aneurysm	0.00352	0.0036	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—intracranial aneurysm	0.00351	0.00359	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—TIMP1—intracranial aneurysm	0.00344	0.00352	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—CTSK—intracranial aneurysm	0.00337	0.00345	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—intracranial aneurysm	0.00334	0.00341	CbGpPWpGaD
Doxycycline—MMP1—Collagen degradation—MMP2—intracranial aneurysm	0.00327	0.00334	CbGpPWpGaD
Doxycycline—MMP13—Collagen degradation—MMP9—intracranial aneurysm	0.00318	0.00325	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—NOS3—intracranial aneurysm	0.00313	0.0032	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—ELN—intracranial aneurysm	0.00311	0.00318	CbGpPWpGaD
Doxycycline—MMP7—Syndecan-1-mediated signaling events—MMP9—intracranial aneurysm	0.00307	0.00314	CbGpPWpGaD
Doxycycline—MMP7—Collagen degradation—MMP9—intracranial aneurysm	0.00307	0.00314	CbGpPWpGaD
Doxycycline—MMP1—Matrix Metalloproteinases—MMP9—intracranial aneurysm	0.00297	0.00303	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—MMP2—intracranial aneurysm	0.00294	0.003	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—intracranial aneurysm	0.00294	0.003	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—CCL2—intracranial aneurysm	0.0029	0.00296	CbGpPWpGaD
Doxycycline—MMP1—Activation of Matrix Metalloproteinases—MMP9—intracranial aneurysm	0.00282	0.00288	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—CTSB—intracranial aneurysm	0.00279	0.00286	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—MMP2—intracranial aneurysm	0.00272	0.00278	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—CTSS—intracranial aneurysm	0.00268	0.00274	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—MMP2—intracranial aneurysm	0.00263	0.00269	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—CTSS—intracranial aneurysm	0.00258	0.00264	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—TIMP1—intracranial aneurysm	0.00256	0.00262	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—NOS3—intracranial aneurysm	0.00255	0.00261	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—intracranial aneurysm	0.00251	0.00257	CbGpPWpGaD
Doxycycline—MMP13—Assembly of collagen fibrils and other multimeric structures—MMP9—intracranial aneurysm	0.00247	0.00253	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—NOS3—intracranial aneurysm	0.00246	0.00252	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—CTSK—intracranial aneurysm	0.00246	0.00252	CbGpPWpGaD
Doxycycline—MMP1—Collagen degradation—MMP9—intracranial aneurysm	0.00246	0.00251	CbGpPWpGaD
Doxycycline—MMP1—Syndecan-1-mediated signaling events—MMP9—intracranial aneurysm	0.00246	0.00251	CbGpPWpGaD
Doxycycline—MMP7—Assembly of collagen fibrils and other multimeric structures—MMP9—intracranial aneurysm	0.00239	0.00244	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—CTSK—intracranial aneurysm	0.00238	0.00243	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—CCL2—intracranial aneurysm	0.00224	0.00229	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—MMP9—intracranial aneurysm	0.00221	0.00226	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—MMP2—intracranial aneurysm	0.00214	0.00219	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—CCL2—intracranial aneurysm	0.00211	0.00215	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—MMP9—intracranial aneurysm	0.0021	0.00214	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—MMP2—intracranial aneurysm	0.00207	0.00212	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—CTSS—intracranial aneurysm	0.00207	0.00211	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—MMP9—intracranial aneurysm	0.00205	0.00209	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—CTSB—intracranial aneurysm	0.00204	0.00208	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—MMP9—intracranial aneurysm	0.00198	0.00202	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—CTSB—intracranial aneurysm	0.00197	0.00201	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—CTSK—intracranial aneurysm	0.0019	0.00194	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—TIMP1—intracranial aneurysm	0.00187	0.00191	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—TIMP1—intracranial aneurysm	0.0018	0.00184	CbGpPWpGaD
Doxycycline—MMP13—Collagen formation—MMP9—intracranial aneurysm	0.00169	0.00172	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—MMP2—intracranial aneurysm	0.00165	0.00169	CbGpPWpGaD
Doxycycline—MMP7—Collagen formation—MMP9—intracranial aneurysm	0.00163	0.00167	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—MMP9—intracranial aneurysm	0.00161	0.00165	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—CTSB—intracranial aneurysm	0.00157	0.00161	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—MMP9—intracranial aneurysm	0.00155	0.00159	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—MMP9—intracranial aneurysm	0.00151	0.00154	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—TIMP1—intracranial aneurysm	0.00144	0.00147	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—MMP9—intracranial aneurysm	0.00124	0.00127	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—MMP2—intracranial aneurysm	0.00123	0.00126	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—MMP9—intracranial aneurysm	0.000925	0.000946	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—MMP2—intracranial aneurysm	0.000898	0.000918	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—MMP2—intracranial aneurysm	0.000867	0.000887	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—TIMP1—intracranial aneurysm	0.000856	0.000875	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—MMP2—intracranial aneurysm	0.000693	0.000709	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—MMP9—intracranial aneurysm	0.000675	0.00069	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—MMP9—intracranial aneurysm	0.000652	0.000666	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—MMP9—intracranial aneurysm	0.000521	0.000533	CbGpPWpGaD
Doxycycline—SLC22A6—brain—intracranial aneurysm	0.000419	0.033	CbGeAlD
Doxycycline—MMP1—Hemostasis—NOS3—intracranial aneurysm	0.000386	0.000395	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—CCL2—intracranial aneurysm	0.00034	0.000348	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—MMP2—intracranial aneurysm	0.000324	0.000331	CbGpPWpGaD
Doxycycline—SLC22A8—brain—intracranial aneurysm	0.000251	0.0198	CbGeAlD
Doxycycline—CYP3A4—Metabolism—SLC25A16—intracranial aneurysm	0.000118	0.000121	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ASAH1—intracranial aneurysm	7.84e-05	8.02e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—NOS3—intracranial aneurysm	1.64e-05	1.67e-05	CbGpPWpGaD
